<DOC>
	<DOCNO>NCT01842269</DOCNO>
	<brief_summary>Efficacy Safety My-Rept速 Tablet ( Mycophenolate Mofetil 500mg/Tab . ) versus My-Rept速 Capsule ( Mycophenolate Mofetil 250mg/Cap . ) Combination Tacrolimus Kidney Transplant Patients</brief_summary>
	<brief_title>Evaluate Efficacy Safety My-Rept速 Tablet vs. My-Rept速 Capsule Combination With Tacrolimus Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1 . Age 20 year old . 2 . Patient receive primary secondary kidney transplantation live braindead donor . 3 . Patient receive age 20 year old donor . 4 . Willing able provide write informed consent . 1 . Cold Ischemia Time &gt; 30 hour . 2 . Patient receive HLAidentical donor . 3 . Patient dual kidney transplantation recipient history organ transplantation past current . 4 . Patient receive extrarenal solid organ bone marrow stem cell transplantation . 5 . Patient receive kidney transplantation nonheart beat cadaveric donor ( organ donor cardiac death 6 . Patient receive kidney transplantation ABO blood type mismatch donor lymphocyte cross matching ( LCM ) positive donor . 7 . Patient cancer within 5 year , except cure skin cancer patient ( Squamous cell basal cell carcinoma ) 8 . Positive serology test ( HIV , HBsAg , HCV ) recipients and/or donor . 9 . Patient Severe gastrointestinal disease screen period investigator 's decision . 10 . Patient systemic severe infection require treatment ( able transplantation completely disappear control infection ) 11 . Liver cirrhosis , clinically significant portal hypertension moderate severe liver disease . 12 . Defined follow laboratory parameter screen period 1 . One liver function test ( AST , ALT , ALP , Total Bilirubin ) result increase 3 time upper limit normal range 2 . WBC &lt; 2,500/mm3 , Platelet &lt; 75,000/mm3 13 . Acute ( within 4 week ) chronic ( need treatment ) allergic/hypersensitivity reaction history Investigational drug ( ex , mycophenolate acid tacrolimus , etc . ) additives . 14 . Administration Investigational drug and/or immunosuppressant within 28days screening period ( except allow immunosuppressant protocol ) 15 . Women pregnant breastfeed n't use adequate contraception . 16 . Patient conversation impairment alcohol drug addiction history within 6months mental illness , etc . 17 . In investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Mycophenolate Mofetil</keyword>
	<keyword>MMF</keyword>
</DOC>